Sripada Chandrasekhar - Dr Reddys President

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:4em;padding-top: 15px;;'>DR</div>
RDY -- USA Stock  

USD 42.35  0.23  0.54%

  President
Dr. Sripada Chandrasekhar, Ph.D., serves as a President, Global Head Human Resources of the Dr.Reddy Laboratories Ltd., since August 2013. Dr Chandrasekhar heads the global HR function with responsibility for all our businesses and markets across the world. Dr. Chandra has the mandate to lead a wide range of HR initiatives in leadership development coaching, talent development, employee engagement and organization design to integrate, grow and transform the organization globally in order to enable the enterprise meet its business objectives.Prior to joining us, Dr. Chandra worked with IBM, India as Vice President Head of Human Resources for the IndiaSouth Asia region. At IBM, he was a key member of the India Leadership Team and a Director on the Board of IBM India
Age: 59  President Since 2013  MBA    
91 40 4900 2900  http://www.drreddys.com
Chandra has done his MBA at the Leeds Business School, United Kingdom and has a Ph.D in Organizational Behavior from Andhra University.

Management Efficiency

The company has Return on Asset of 6.98 % which means that on every $100 spent on asset it made $6.98 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.75 % implying that it generated $18.75 on every 100 dollars invested.
The company has 811.73 M in debt with debt to equity (D/E) ratio of 20.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories has Current Ratio of 1.92 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

PRESIDENT Since

Paul SilvaVertex Pharmaceuticals Incorpor
2019
Grainne QuinnPerrigo Company Plc
2016
Clinton LewisZoetis
2018
John WesolowskiPerrigo Company Plc
2016
Jatin ShahPerrigo Company Plc
2005
Scott JamisonPerrigo Company Plc
2011
Christopher FenimoreRegeneron Pharmaceuticals
2017
Daniel PlewRegeneron Pharmaceuticals
2016
Marion McCourtRegeneron Pharmaceuticals
2018
Ronald JanishPerrigo Company Plc
2015
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
Charles WagnerVertex Pharmaceuticals Incorpor
2019
Jeffrey NeedhamPerrigo Company Plc
2009
Svend AndersenPerrigo Company Plc
2017
Thomas FarringtonPerrigo Company Plc
2015
Glenn DavidZoetis
2016
Michael AbermanRegeneron Pharmaceuticals
2015
Andrew FentonZoetis
2018
Douglas BoothePerrigo Company Plc
2013
Michael PariniVertex Pharmaceuticals Incorpor
2017
Stefan WeiskopfZoetis
2013

Entity Summary

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people.

Dr Reddys Laboratories Leadership Team

G Prasad, Co-Chairman of the Board, Chief Executive Officer, Managing Director
MARC KIKUCHI, Chief Executive Officer, North America Generics
Hans Hasler, Additional Independent Director
Leo Puri, Non-Executive Independent Director
Sandeep Poddar, Compliance Officer, Company Secretary
Satish Reddy, Co-Chairman of the Board
Kedar Upadhye, IR Contact Officer
Samiran Das, Executive Vice President Head - FTO and GGPM
Sauri Gudlavalleti, Global Head of Integrated Product Development Organization
YUGANDHAR PUVVALA, Global Head of Supply Chain
Amit Biswas, Executive Vice President - Integrated Product Development
Ravi Bhoothalingam, Non-Executive Independent Director
Alok Sonig, Senior Vice President & India Business Head (Generics)
Allan Oberman, Non-Executive Independent Director
J Ramachandran, Executive Vice President-Management Systems and Corporate Initiatives
Prasad Menon, Lead Non-Executive Independent Director
K Rao, Sr. Vice President & Head ? Chemical Technical Operations (CTO)
Abhijit Mukherjee, COO
Anil Namboodiripad, Global Head of Proprietary Products
Saumen Chakraborty, President, Chief Financial Officer and Global Head of ITBPE, Legal & Compliance and FMCRE
SANJAY SHARMA, Global Head of Manufacturing
Shikha Sharma, Non-Executive Independent Director
Sridar Iyengar, Non-Executive Independent Director
Ganadhish Kamat, Executive Vice President and Global Head-Quality
Sripada Chandrasekhar, President, Global Head of HR and Member of Management Council
Omkar Goswami, Non-Executive Independent Director
Erez Israeli, Chief Operating Officer and Global Head of Generics & PSAI
Kalpana Morparia, Non-Executive Independent Director
Bharat Doshi, Non-Executive Independent Director
J Moreau, Non-Executive Independent Director
Raymond Vre, Global Head of Biologics
Raghav Chari, Senior Vice President - Proprietary Products
Bruce Carter, Non-Executive Independent Director
Saunak Savla, IR Contact Officer
Ashok Ganguly, Non-Executive Independent Director
Umang Vohra, Executive Vice President Head - North America Generics
M Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets)
Cartikeya Reddy, Senior Vice President Head - Biologics
Anupam Puri, Non-Executive Independent Director
Archana Bhaskar, Chief Human Resource Officer
Deepak Sapra, Global Head of PSAI

Stock Performance Indicators

Current Sentiment - RDY

Dr Reddys Laboratories Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Dr Reddys Laboratories Ltd. What is your opinion about investing in Dr Reddys Laboratories Ltd? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

C   
Purchased over 30 shares of
few hours ago
Traded for 80.1
F   
Purchased over 300 shares of
few hours ago
Traded for 9.16
CRSP   
Purchased over 50 shares of
few hours ago
Traded for 58.39
GM   
Purchased over 70 shares of
few hours ago
Traded for 34.91
S   
Purchased over 500 shares of
few hours ago
Traded for 5.02
Additionally take a look at Your Equity Center. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.